Literature DB >> 12581944

Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users.

M P Carrieri1, M A Chesney, B Spire, A Loundou, A Sobel, G Lepeu, J P Moatti.   

Abstract

The study, carried out in the French MANIF 2000 cohort of HIV positive patients contaminated through injecting drug use, assessed the impact of patients' sociodemographic and psychological characteristics, behaviors toward drug abuse, and antiretroviral treatment characteristics on the maintenance of adherence to HAART (highly active antiretroviral therapies). A total of 96 patients (30 men and 66 women), who were initially adherent at their first visit after HAART prescription, were considered for analysis. Among these 96 patients, 22 (22.9%) experienced adherence failure defined as a self-reported, non-adherence behavior at any visit before the 18th month of treatment. Logistic regression showed that lack of a stable relationship, active drug injection, and depression were independently associated with adherence failure. Patients' counseling for facilitating maintenance of adherence to HAART over time should focus on prevention of drug use, provision of social support and consider the potential impact of difficulties with treatment on psychological well-being.

Entities:  

Mesh:

Year:  2003        PMID: 12581944     DOI: 10.1207/s15327558ijbm1001_01

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  52 in total

1.  Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy.

Authors:  S Duran; M Savès; B Spire; V Cailleton; A Sobel; P Carrieri; D Salmon; J P Moatti; C Leport
Journal:  AIDS       Date:  2001-12-07       Impact factor: 4.177

2.  Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

Authors:  R S Hogg; K V Heath; B Yip; K J Craib; M V O'Shaughnessy; M T Schechter; J S Montaner
Journal:  JAMA       Date:  1998-02-11       Impact factor: 56.272

3.  Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.

Authors:  J J Eron; E S Yetzer; P J Ruane; S Becker; G A Sawyer; R L Fisher; J M Tolson; M S Shaefer
Journal:  AIDS       Date:  2000-04-14       Impact factor: 4.177

4.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Authors:  G M Lucas; L W Cheever; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

5.  Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

Authors:  S Duran; B Spire; F Raffi; V Walter; D Bouhour; V Journot; V Cailleton; C Leport; J P Moatti
Journal:  HIV Clin Trials       Date:  2001 Jan-Feb

6.  Problem drinking and medication adherence among persons with HIV infection.

Authors:  R L Cook; S M Sereika; S C Hunt; W C Woodward; J A Erlen; J Conigliaro
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

7.  Predictors of nonadherence to HIV-related medication regimens during methadone stabilization.

Authors:  S K Avants; A Margolin; L A Warburton; K A Hawkins; J Shi
Journal:  Am J Addict       Date:  2001

Review 8.  Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.

Authors:  V E Stone
Journal:  Clin Infect Dis       Date:  2001-08-13       Impact factor: 9.079

9.  Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.

Authors:  S L Catz; J A Kelly; L M Bogart; E G Benotsch; T L McAuliffe
Journal:  Health Psychol       Date:  2000-03       Impact factor: 4.267

10.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

View more
  27 in total

1.  Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals.

Authors:  Alan R Templeton; Rebecca A Reichert; Anton E Weisstein; Xiao-Fang Yu; Richard B Markham
Journal:  Genetics       Date:  2004-08       Impact factor: 4.562

2.  "It's Not What You Know but Who You Know": Role of Social Capital in Predicting Risky Injection Drug Use Behavior in a Sample of People who Inject Drugs in Baltimore City.

Authors:  Pritika C Kumar; Jennifer McNeely; Carl A Latkin
Journal:  J Subst Use       Date:  2016-05-09

3.  Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use.

Authors:  Aaron J Blashill; Janna R Gordon; Steven A Safren
Journal:  J Behav Med       Date:  2012-11-22

Review 4.  Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.

Authors:  Olalekan A Uthman; Jessica F Magidson; Steven A Safren; Jean B Nachega
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

5.  Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.

Authors:  Amy R Knowlton; Julia H Arnsten; Lois J Eldred; James D Wilkinson; Starley B Shade; Amy S Bohnert; Cui Yang; Lawrence S Wissow; David W Purcell
Journal:  AIDS Patient Care STDS       Date:  2010-07       Impact factor: 5.078

6.  To tell or not to tell: why people with HIV share or don't share with their physicians whether they are taking their medications as prescribed.

Authors:  H Kremer; G Ironson
Journal:  AIDS Care       Date:  2006-07

7.  Factors associated with utilization of HAART amongst hard-to-reach HIV-infected individuals in Atlanta, Georgia.

Authors:  Paulina Rebolledo; Ekaterina Kourbatova; Richard Rothenberg; Carlos Del Rio
Journal:  J AIDS HIV Res       Date:  2011-03

8.  Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics.

Authors:  Nathaniel A Sowa; Angela Bengtson; Bradley N Gaynes; Brian W Pence
Journal:  J Affect Disord       Date:  2015-12-22       Impact factor: 4.839

9.  Patterns and determinants of inappropriate antibiotic use in injection drug users.

Authors:  Joanna L Starrels; Frances K Barg; Joshua P Metlay
Journal:  J Gen Intern Med       Date:  2008-12-12       Impact factor: 5.128

10.  The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance.

Authors:  Howard Newville; Karina M Berg; Jeffrey S Gonzalez
Journal:  Int J Behav Med       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.